Cargando…
Synergistic activation of AMPK prevents from polyglutamine-induced toxicity in Caenorhabditis elegans
Expression of abnormally long polyglutamine (polyQ) tracks is the source of a range of dominant neurodegenerative diseases, such as Huntington disease. Currently, there is no treatment for this devastating disease, although some chemicals, e.g., metformin, have been proposed as therapeutic solutions...
Autores principales: | Gómez-Escribano, AP, Bono-Yagüe, J, García-Gimeno, MA, Sequedo, MD, Hervás, D, Fornés-Ferrer, V, Torres-Sánchez, SC, Millán, JM, Sanz, P, Vázquez-Manrique, RP |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755709/ https://www.ncbi.nlm.nih.gov/pubmed/32739430 http://dx.doi.org/10.1016/j.phrs.2020.105105 |
Ejemplares similares
-
Metformin intake associates with better cognitive function in patients with Huntington's disease
por: Hervás, David, et al.
Publicado: (2017) -
An AMPK biosensor for
Caenorhabditis elegans
por: Carman, Lynly, et al.
Publicado: (2022) -
Salidroside Protects Caenorhabditis elegans Neurons from Polyglutamine-Mediated Toxicity by Reducing Oxidative Stress
por: Xiao, Lingyun, et al.
Publicado: (2014) -
Uncoupling the Trade-Off between Somatic Proteostasis and Reproduction in Caenorhabditis elegans Models of Polyglutamine Diseases
por: Shemesh, Netta, et al.
Publicado: (2017) -
Calcineurin Antagonizes AMPK to Regulate Lipolysis in Caenorhabditis elegans
por: Wang, Yanli, et al.
Publicado: (2017)